.
Defensive pharma stocks with operating profit margins of more than 85% to add to your watchlist

Defensive pharma stocks with operating profit margins of more than 85% to add to your watchlist

India is the largest global supplier of generic drugs and he Indian pharmaceutical industry is growing rapidly, projected to reach $65 billion by 2024 and $130 billion by 2030. Growth is driven by increasing R&D investments, government initiatives, and rising domestic healthcare demand  Operating profit margin is a financial metric that measures the proportion of [...]
×